Garry E Menzel's Net Worth
Garry E Menzel's net worth is estimated to be at least $101,785.67 as of 04/28/2024. CoreStreet's estimation of Garry E Menzel's net worth is based on their sale of stock and current holding of stock.
Garry E Menzel is Director at Adaptimmune Therapeutics Plc. They have executed at least 6 trades of stock as per SEC Form 4 filings. Their most recent trade was for 47,702 units of ADAP stock on 07/10/2023. Their biggest sale was on 07/10/2023 when they sold 47,702 units of Adaptimmune Therapeutics Plc stock for $43,408.82. They typically trade 3 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $101,785.67
Most recent insider trade:
- July 10, 2023
Garry E Menzel's Insider Trading History
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 10, 2023 | Director | 47,702 | $0.91 | Sell | $43,408.82 |
| Tcr2 Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 12, 2022 | CEO | 10,613 | $1.10 | Sell | $11,674.30 |
Dec. 9, 2022 | CEO | 10,325 | $1.13 | Sell | $11,667.25 |
Dec. 7, 2022 | CEO | 9,111 | $1.28 | Sell | $11,662.08 |
Dec. 5, 2022 | CEO | 8,530 | $1.37 | Sell | $11,686.10 |
Dec. 2, 2022 | CEO | 8,408 | $1.39 | Sell | $11,687.12 |